Background PDZK1 is a four PDZ-domain containing cytoplasmic protein that binds to a variety of membrane proteins via their C-termini and can influence the abundance, localization and/or function of its target proteins. One of these targets in hepatocytes in vivo is the HDL receptor SR-BI. Normal hepatic expression of SR-BI protein requires PDZK1 - <5% of normal hepatic SR-BI is seen in the livers of PDZK1 knockout mice. Progress has been made in identifying features of PDZK1 required to control hepatic SR-BI in vivo using hepatic expression of wild-type and mutant forms of PDZK1 in wild-type and PDZK1 KO transgenic mice. Such in vivo studies are time consuming and expensive, and cannot readily be used to explore many features of the underlying molecular and cellular mechanisms. Methodology/Principal Findings Here we have explored the potential to use either primary rodent hepatocytes in culture using 2D collagen gels with newly developed optimized conditions or PDZK1/SR-BI co-transfected cultured cell lines (COS, HEK293) for such studies. SR-BI and PDZK1 protein and mRNA expression levels fell rapidly in primary hepatocyte cultures, indicating this system does not adequately mimic hepatocytes in vivo for analysis of the PDZK1 dependence of SR-BI. Although PDZK1 did alter SR-BI protein expression in the cell lines, its influence was independent of SR-BI’s C-terminus, and thus is not likely to occur via the same mechanism as that which occurs in hepatocytes in vivo. Conclusions/Significance Caution must be exercised in using primary hepatocytes or cultured cell lines when studying the mechanism underlying the regulation of hepatic SR-BI by PDZK1. It may be possible to use SR-BI and PDZK1 expression as sensitive markers for the in vivo-like state of hepatocytes to further improve primary hepatocyte cell culture conditions.
References
[1]
Gordon DJ, Rifkind BM (1989) High-density lipoprotein–the clinical implications of recent studies. N Engl J Med 321: 1311–1316.
[2]
Kannel BW, Castelli WP, Gordon T, McNamara PM (1971) Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med 74: 1–12.
[3]
Rigotti A, Miettinen HE, Krieger M (2003) The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues. Endocr Rev 24: 357–387.
[4]
Kozarsky KF, Donahee MH, Rigotti A, Iqbal SN, Edelman ER, et al. (1997) Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 387: 414–417.
[5]
Rigotti A, Trigatti BL, Penman M, Rayburn H, Herz J, et al. (1997) A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci U S A 94: 12610–12615.
[6]
Oquendo P, Hundt E, Lawler J, Seed B (1989) CD36 directly mediates cytoadherence of Plasmodium falciparum infected erythrocytes. Cell 58: 95–101.
[7]
Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, et al. (1996) Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271: 518–520.
[8]
Out R, Kruijt JK, Rensen PC, Hildebrand RB, de Vos P, et al. (2004) Scavenger receptor BI plays a role in facilitating chylomicron metabolism. J Biol Chem 279: 18401–18406.
[9]
Out R, Hoekstra M, de Jager SC, de Vos P, van der Westhuyzen DR, et al. (2005) Adenovirus-mediated hepatic overexpression of scavenger receptor class B type I accelerates chylomicron metabolism in C57BL/6J mice. J Lipid Res 46: 1172–1181.
[10]
Fu T, Kozarsky KF, Borensztajn J (2003) Overexpression of SR-BI by adenoviral vector reverses the fibrateinduced hypercholesterolemia of apolipoprotein E-deficient mice. J Biol Chem 278: 52559–52563.
[11]
Glass C, Pittman RC, Weinstein DW, Steinberg D (1983) Dissociation of tissue uptake of cholesterol from that of apoprotein A-I of rat high density lipoproteins: selective delivery of cholesterol to liver, adrenal and gonad. Proc Natl Acad Sci USA 80: 5435–5439.
[12]
Glass C, Pittman RC, Civen M, Steinberg D (1985) Uptake of high-density lipoprotein-associated apoprotein A-I and cholesterol esters by 16 tissues of the rat in vivo and by adrenal cells and hepatocytes in vitro. J Biol Chem 260: 744–750.
[13]
Stein Y, Dabach Y, Hollander G, Halperin G, Stein O (1983) Metabolism of HDL-cholesteryl ester in the rat, studied with a nonhydrolyzable analog, cholesteryl linoleyl ether. Biochim Biophys Acta 752: 98–105.
[14]
Ji Y, Jian B, Wang N, Sun Y, de la Llera Moya M, et al. (1997) Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem 272: 20982–20985.
[15]
Landschulz KT, Pathak RK, Rigotti A, Krieger M, Hobbs HH (1996) Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. J Clin Invest 98: 984–995.
[16]
Webb NR, de Villiers WJ, Connell PM, de Beer FC, van der Westhuyzen DR (1997) Alternative forms of the scavenger receptor BI (SR-BI). J Lipid Res 38: 1490–1495.
[17]
Trigatti B, Rayburn H, Vi？als M, Braun A, Miettinen H, et al. (1999) Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc Natl Acad Sci U S A 96: 9322–9327.
[18]
Miettinen HE, Rayburn H, Krieger M (2001) Abnormal lipoprotein metabolism and reversible female infertility in HDL receptor (SR-BI)-deficient mice. J Clin Invest 108: 1717–1722.
[19]
Holm TM, Braun A, Trigatti BL, Brugnara C, Sakamoto M, et al. (2002) Failure of red blood cell maturation in mice with defects in the high-density lipoprotein receptor SR-BI. Blood 99: 1817–1824.
[20]
Meurs I, Hoekstra M, van Wanrooij EJ, Hildebrand RB, Kuiper J, et al. (2005) HDL cholesterol levels are an important factor for determining the lifespan of erythrocytes. Exp Hematol 33: 1309–1319.
[21]
Dole VS, Matuskova J, Vasile E, Yesilaltay A, Bergmeier W, et al. (2008) Thrombocytopenia and platelet abnormalities in high-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 28: 1111–1116.
[22]
Korporaal SJ, Meurs I, Hauer AD, Hildebrand RB, Hoekstra M, et al. (2011) Deletion of the high-density lipoprotein receptor scavenger receptor BI in mice modulates thrombosis susceptibility and indirectly affects platelet function by elevation of plasma free cholesterol. Arterioscler Thromb Vasc Biol 31: 34–42.
[23]
Brill A, Yesilaltay A, De Meyer SF, Kisucka J, Fuchs TA, et al. (2012) Extrahepatic high-density lipoprotein receptor SR-BI and apoA-I protect against deep vein thrombosis in mice. Arterioscler Thromb Vasc Biol 32: 1841–1847.
[24]
Cai L, Ji A, de Beer FC, Tannock LR, van der Westhuyzen DR (2008) SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance. J Clin Invest 118: 364–375.
[25]
Scarselli E, Ansuini H, Cerino R, Roccasecca RM, Acali S, et al. (2002) The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus EMBO J. 21: 5017–5025.
[26]
Eyre NS, Drummer HE, Beard MR (2010) The SR-BI partner PDZK1 facilitates hepatitis C virus entry. PLoS Pathog 6: e1001130.
[27]
Zahid MN, Turek M, Xiao F, Thi VL, Guérin M, et al.. (2012) The post-binding activity of scavenger receptor BI mediates initiation of hepatitis C virus infection and viral dissemination. Hepatology doi: 10.1002/hep.26097. [Epub ahead of print].
[28]
Braun A, Trigatti BL, Post MJ, Sato K, Simons M, et al. (2002) Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ Res 90: 270–276.
[29]
Yuhanna IS, Zhu Y, Cox BE, Hahner LD, Osborne-Lawrence S, et al. (2001) High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase. Nat Med 7: 853–857.
[30]
Saddar S, Mineo C, Shaul PW (2010) Signaling by the high-affinity HDL receptor scavenger receptor B type I. Arterioscler Thromb Vasc Biol. 30: 144–150.
[31]
Murao K, Terpstra V, Green SR, Kondratenko N, Steinberg D, et al. (1997) Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes. J Biol Chem 272: 17551–17557.
[32]
Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, et al. (2011) Genetic variant of the scavenger receptor BI in humans. N Engl J Med 364: 136–145.
[33]
Yalaoui S, Huby T, Franetich JF, Gego A, Rametti A, et al. (2008) Scavenger receptor BI boosts hepatocyte permissiveness to Plasmodium infection. Cell Host Microbe 4: 283–292.
[34]
Rodrigues CD, Hannus M, Prudêncio M, Martin C, Gon？alves LA, et al. (2008) Host scavenger receptor SR-BI plays a dual role in the establishment of malaria parasite liver infection. Cell Host Microbe 4: 271–282.
[35]
Ikemoto M, Arai H, Feng D, Tanaka K, Aoki J, et al. (2000) Identification of a PDZ-domain-containing protein that interacts with the scavenger receptor class B type I. Proc Natl Acad Sci U S A. 97: 6538–6543.
[36]
Kocher O, Yesilaltay A, Cirovic C, Pal R, Rigotti A, et al. (2003) Targeted disruption of the PDZK1 gene in mice causes tissue-specific depletion of the high density lipoprotein receptor scavenger receptor class B type I and altered lipoprotein metabolism. J Biol Chem 278: 52820–52825.
[37]
Fenske SA, Yesilaltay A, Pal R, Daniels K, Barker C, et al. (2009) Normal hepatic cell surface localization of the high density lipoprotein receptor, scavenger receptor class B, type I, depends on all four PDZ domains of PDZK1. J Biol Chem 284: 5797–5806.
[38]
Kocher O, Yesilaltay A, Shen CH, Zhang S, Daniels K, et al. (2008) Influence of PDZK1 on lipoprotein metabolism and atherosclerosis. Biochim Biophys Acta 1782: 310–316.
[39]
Yesilaltay A, Daniels K, Pal R, Krieger M, Kocher O (2009) Loss of PDZK1 causes coronary artery occlusion and myocardial infarction in Paigen diet-fed apolipoprotein E deficient mice. PLoS One 4: e8103.
[40]
Kocher O, Krieger M (2009) Role of the adaptor protein PDZK1 in controlling the HDL receptor SR-BI. Curr Opin Lipidol 20: 236–241.
[41]
Yesilaltay A, Kocher O, Rigotti A, Krieger M (2005) Regulation of SR-BI-mediated high-density lipoprotein metabolism by the tissue-specific adaptor protein PDZK1. Curr Opin Lipidol 16: 147–152.
[42]
Fenske SA, Yesilaltay A, Pal R, Daniels K, Rigotti A, et al. (2008) Overexpression of the PDZ1 domain of PDZK1 blocks the activity of hepatic scavenger receptor, class B, type I by altering its abundance and cellular localization. J Biol Chem 283: 22097–22104.
[43]
Kocher O, Birrane G, Tsukamoto K, Fenske S, Yesilaltay A, et al. (2010) In vitro and in vivo analysis of the binding of the C terminus of the HDL receptor scavenger receptor class B, type I (SR-BI), to the PDZ1 domain of its adaptor protein PDZK1. J Biol Chem 285: 34999–35010.
[44]
Kocher O, Birrane G, Yesilaltay A, Shechter S, Pal R, et al. (2011) Identification of the PDZ3 Domain of the Adaptor Protein PDZK1 as a Second, Physiologically Functional Binding Site for the C Terminus of the High Density Lipoprotein Receptor Scavenger Receptor Class B Type I. J Biol Chem. 286: 25171–25186.
[45]
a. Tsukamoto K, Wales TE, Daniels K, Pal R, Sheng R, et al.. (2013) Non-Canonical Role of the PDZ4 domain of the Adaptor Protein PDZK1 in the Regulation of the Hepatic HDL receptor SR-BI. J. Biol. Chem. In press.
[46]
Silver DL (2002) A carboxyl-terminal PDZ-interacting domain of scavenger receptor B, type I is essential for cell surface expression in liver. J Biol Chem 277: 34042–34047.
[47]
Maslansky CJ, Williams GM (1982) Primary Cultures and the Levels of Cytochrome P450 in Hepatocytes from Mouse, Rat, Hamster, and Rabbit Liver. In Vitro 18: 683–693.
[48]
LeCluyse E, Bullock P, Madan A, Carroll K, Parkinson A (1999) Influence of Extracellular Matrix Overlay and Medium Formulation on the Induction of Cytochrome P-450 2B Enzymes in Primary Cultures of Rat Hepatocytes. Drug Metabolism and Disposition 27: 909–915.
[49]
Klaunig JE, Goldblatt PJ, Hinton DE, Lipsky MM, Chacko J, et al. (1981) Mouse Liver Cell Culture. I. Hepatocyte Isolation. In Vitro 17: 913–925.
[50]
Sivaraman A, Leach JK, Townsend S, Iida T, Hogan BJ, et al. (2005) A Microscale In Vitro Physiological Model of the Liver: Predictive Screens for Drug Metabolism and Enzyme Induction. Current Drug Metabolism 6: 569–591.
[51]
Bissell DM, Caron JM, Babiss LE, Friedman SL (1990) Transcriptional regulation of the albumin gene in cultured rat hepatocytes: role of basement membrane matrix. Mol Biol Med 7: 187–197.
[52]
Stylianou IM, Svenson KL, VanOrman SK, Langle Y, Millar JS, et al. (2009) Novel ENU-induced point mutation in scavenger receptor class B, member 1, results in liver specific loss of SCARB1 protein. PLoS One 4: e6521.
[53]
Hwa AJ, Fry RC, Sivaraman A, So PT, Samson LD, et al. (2007) Rat liver sinusoidal endothelial cells survive without exogenous VEGF in 3D perfused co-cultures with hepatocytes. FASEB J 21: 2564–2579.
[54]
Richert L, Binda D, Hamilton G, Viollon-Abadie C, Alexandre E, et al. (2002) Evaluation of the effect of culture configuration on morphology, survival time, antioxidant status and metabolic capacities of cultured rat hepatocytes. Toxicology in Vitro 16: 89–99.
[55]
Yesilaltay A, Kocher O, Pal R, Leiva A, Qui？ones V, et al. (2006) PDZK1 is required for maintaining hepatic scavenger receptor, class B, type I (SR-BI) steady state levels but not its surface localization or function. J Biol Chem 281: 28975–28980.
[56]
Nieland TJ, Xu S, Penman M, Krieger M (2011) Negatively cooperative binding of high-density lipoprotein to the HDL receptor SR-BI. Biochemistry 50: 1818–1830.
[57]
Gu X, Kozarsky K, Krieger M (2000) Scavenger receptor class B, type I-mediated [3H]cholesterol efflux to high and low density lipoproteins is dependent on lipoprotein binding to the receptor. J Biol Chem 275: 29993–30001.
[58]
Guo Q, Vasile E, Krieger M (1994) Disruptions in Golgi structure and membrane traffic in a conditional lethal mammalian cell mutant are corrected by ε-COP. J Cell Biol 125: 1213–1224.
[59]
Martinez SM, Bradford BU, Soldatow VY, Kosyk O, Sandot A, et al. (2010) Evaluation of an in vitro toxicogenetic mouse model for hepatotoxicity. Toxicol Appl Pharmacol 249: 208–216.
[60]
Michalopoulos G, Pitot HC (1975) Primary culture of parenchymal liver cells on collagen membranes. Morphological and biochemical observations. Exp Cell Res 94: 70–78.
[61]
Shih SC, Zukauskas A, Li D, Liu G, Ang LH, et al. (2009) The L6 protein TM4SF1 is critical for endothelial cell function and tumor angiogenesis. Cancer Res 69 (8): 3272–3277.
[62]
Shih SC, Smith LE (2005) Quantitative multi-gene transcriptional profiling using real-time PCR with a master template. Exp Mol Pathol 79 (1): 14–22.
[63]
Wada Y, Li D, Merley A, Zukauskas A, Aird WC, et al. (2011) A multi-gene transcriptional profiling approach to the discovery of cell signature markers. Cytotechnology 63(1): 25–33.
[64]
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275.
